GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » The Chemours Co (NYSE:CC) » Definitions » Cash, Cash Equivalents, Marketable Securities

The Chemours Co (The Chemours Co) Cash, Cash Equivalents, Marketable Securities : $1,203 Mil (As of Dec. 2023)


View and export this data going back to 2015. Start your Free Trial

What is The Chemours Co Cash, Cash Equivalents, Marketable Securities?

The Chemours Co's quarterly cash, cash equivalents, marketable securities increased from Jun. 2023 ($738.00 Mil) to Sep. 2023 ($852.00 Mil) and increased from Sep. 2023 ($852.00 Mil) to Dec. 2023 ($1,203.00 Mil).

The Chemours Co's annual cash, cash equivalents, marketable securities declined from Dec. 2021 ($1,451.00 Mil) to Dec. 2022 ($1,102.00 Mil) but then increased from Dec. 2022 ($1,102.00 Mil) to Dec. 2023 ($1,203.00 Mil).


The Chemours Co Cash, Cash Equivalents, Marketable Securities Historical Data

The historical data trend for The Chemours Co's Cash, Cash Equivalents, Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

The Chemours Co Cash, Cash Equivalents, Marketable Securities Chart

The Chemours Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cash, Cash Equivalents, Marketable Securities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 943.00 1,105.00 1,451.00 1,102.00 1,203.00

The Chemours Co Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cash, Cash Equivalents, Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,102.00 816.00 738.00 852.00 1,203.00

The Chemours Co Cash, Cash Equivalents, Marketable Securities Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.


The Chemours Co  (NYSE:CC) Cash, Cash Equivalents, Marketable Securities Explanation

Marketable securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.


The Chemours Co Cash, Cash Equivalents, Marketable Securities Related Terms

Thank you for viewing the detailed overview of The Chemours Co's Cash, Cash Equivalents, Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.


The Chemours Co (The Chemours Co) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » The Chemours Co (NYSE:CC) » Definitions » Cash, Cash Equivalents, Marketable Securities
Traded in Other Exchanges
Address
1007 Market Street, Wilmington, DE, USA, 19801
The Chemours Co is a global provider of chemicals. It delivers customized solutions with a wide range of industrial and specialty chemicals products for various markets including coatings, plastics, refrigeration, air conditioning, etc. The company's operating segments include Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. It generates maximum revenue from the Titanium Technologies segment. The Titanium Technologies segment is a producer of TiO2 pigment, a premium white pigment used to deliver whiteness, brightness, opacity, durability, efficiency, and protection across a variety of applications. Geographically, it derives a majority of its revenue from North America.
Executives
Ron Christopher Charles officer: Senior Vice President, People C/O THE CHEMOURS COMPANY, 1007 MARKET STREET, WILMINGTON DE 19801
Sandra Phillips Rogers director 1000 CRANBERRY WOODS DRIVE, CRANBERRY TOWNSHIP PA 16066
Erin N Kane director 300 KIMBALL DRIVE, SUITE 101, PARSIPPANY NJ 07054
Joseph T. Martinko officer: President, Thermal & Specializ C/O THE CHEMOURS COMPANY, 1007 MARKET STREET, WILMINGTON DE 19801
Mark Newman officer: Senior Vice President and CFO 1011 WARRENVILLE ROAD, SUITE 600, LISLE IL 60532
Alvenia Scarborough officer: SVP Corp Communications & CBO C/O THE CHEMOURS COMPANY, 1007 MARKET STREET, WILMINGTON DE 19801
Matthew S Abbott officer: SVP, Chief Enterprise Transfor C/O THE CHEMOURS COMPANY, 1007 MARKET STREET, WILMINGTON DE 19801
Guillaume Pepy director C/O THE CHEMOURS COMPANY, 1007 MARKET STREET, WILMINGTON DE 19801
Sean D Keohane director C/O CABOT CORPORATION, TWO SEAPORT LANE, SUITE 1300, BOSTON MA 02210
Calderon Gerardo Familiar officer: Pres Advanced Performance Mat C/O THE CHEMOURS COMPANY, 1007 MARKET STREET, WILMINGTON DE 19801
Alisha Bellezza officer: President, Thermal Spec Solns C/O THE CHEMOURS COMPANY, 1007 MARKET STREET, WILMINGTON DE 19801
Camela Wisel officer: VP, CAO & Controller C/O THE CHEMOURS COMPANY, 1007 MARKET STREET, WILMINGTON DE 19801
Sameer Ralhan officer: SVP, CFO C/O THE CHEMOURS COMPANY, 1007 MARKET STREET, WILMINGTON DE 19899
Jonathan Lock officer: SVP, Chief Development Officer C/O THE CHEMOURS COMPANY, 1007 MARKET STREET, WILMINGTON DE 19801
Susan M. Kelliher officer: SVP, People and Health Service ALBEMARLE CORPORATION, 451 FLORIDA STREET, BATON ROUGE LA 70801